Key facts
- Notable investors include Highlight Capital, Hangzhou Xihu Industry Fund Management, Chinese Academy of Sciences Holdings, Guoke Dongfang Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Nextech Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Nextech Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nextech Biotechnology
Manufacturer of customized new drug delivery devices intended to advance the development of new drug delivery technologies and support improved medical device quality management. The company offers new drug delivery devices and pharmaceutical packaging materials, thereby enabling customers to solve the manufacturing and clinical use challenges of pharmaceuticals.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2021
- Website
- nextech-x.com/
- Ownership
- Privately Held (backing)
Nextech Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nextech Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nextech Biotechnology in its N-PORT filings yet. We sweep new filings monthly.